The GLP is committed to full transparency. Download and review our Annual Report.

Two US Congressional committees ask IARC cancer agency to testify, citing ‘scientific integrity’ concerns

| | November 2, 2017

Two influential U.S. Congressmen have asked the World Health Organization’s cancer agency to get ready to testify about its work assessing if substances cause cancer, citing concerns about its “scientific integrity”.

Their letter to the International Agency for Research on Cancer (IARC), seen by Reuters and sent on Wednesday, is part of ongoing investigations by two Congressional committees into IARC that were fueled by the agency’s review of glyphosate, the primary ingredient of Monsanto Co’s weedkiller Roundup.

A letter to IARC director Chris Wild from the Republican chairmen of the House Committee on Science and the Subcommittee on Environment said they are “concerned about the scientific integrity” of IARC’s “monograph” program, which assesses whether various substances can cause cancer in people.

Related article:  Facing 10,000 plus glyphosate-cancer lawsuits, Bayer enters court-ordered mediation with next plaintiff

In a second letter seen by Reuters, the Congressmen, Lamar Smith and Andy Biggs, expressed concern that IARC’s assessment meetings, deliberations and drafts are not made public.

“It is an affront to scientific integrity to keep ‘confidential’ a scientific process that directly influences policy and individual taxpayers,” Smith and Biggs wrote.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Exclusive: Congressional committee questions operation of WHO cancer agency

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend